Tatjana Rundek, MD, PhD, FANA
Tatjana Rundek, MD, PhD, FANA
Director, Evelyn F. McKnight Brain Institute
Professor of Neurology and Public Health Sciences
Evelyn F. McKnight Endowed Chair for
Learning and Memory in Aging
Executive Vice Chair of Research and Faculty Affairs, Neurology
Executive Vice Chair of Research and Faculty Affairs
Chief, Clinical Translational Research Division
Department of Neurology
Director, Master of Science in Clinical Translational Investigations
Miller School of Medicine, University of Miami
1120 NW 14th Street, CRB- 1348
Miami, FL 33136
Phone: 305-243-7847
Tatjana Rundek, M.D., Ph.D., is a vascular and cognitive neurologist, clinical researcher and leader of several programs and projects on determinants of stroke, age-related memory loss, cognitive decline and brain health. She serves as a professor of neurology, executive vice chair of research and faculty affairs, and director of the University of Miami Miller School of Medicine Department of Neurology Clinical Translational Research Division in Florida. She also is director of the Evelyn F. McKnight Brain Institute at the University of Miami.
Dr. Rundek completed a neurology and research fellowship at Columbia University in New York City. She was the first Fulbright Scholar at the Neurological Institute of New York – Columbia University Irving Medical Center.
Dr. Rundek is a collaborative scientist-investigator with over 550 peer-reviewed publications, editorials and book chapters. She has extensive research networks with multiple national and international research teams, including investigators from Columbia University on large National Institutes of Health (NIH)-funded population-based studies of age-related neurovascular disease and the Einstein Aging Study on vascular cognitive decline. She serves as a team scientist-leader of large international stroke and aging projects and consortia, including the National Institute on Aging (NIA)-funded Precision Aging Network.
Dr. Rundek is a dedicated educator and mentor who leads educational and mentorship programs. She serves as training director of two large National Institute of Neurological Disorders and Stroke-funded clinical trial networks, StrokeNet and NeuroNEXT. She is director of the NIA-funded 1Florida Alzheimer’s Disease Research Center Research Education Program and director of the University of Miami master of science in clinical translational investigation program and the K12 mentored career development research training program at the University of Miami Clinical Translational Science Institute. She was a recipient of an American Heart Association Mentor Award and an NIH K24 research training and career development grant.
Dr. Rundek has been an active member of a broader professional and scientific community. She is a section editor of Stroke for Brain Health and serves on the editorial boards of several influential scientific journals, including Neurology, Journal of Ultrasound in Medicine and Cerebrovascular Diseases. She also serves on the NIH and other professional organizations’ grant review study sections. She is a fellow of the American Heart Association (AHA) and American Academy of Neurology. She is immediate past president of the Intersocietal Accreditation Commission Vascular Testing Board of Directors, a U.S. organization that accredits clinical nuclear, PET, MRI, CT, ultrasound and carotid stenting programs. Dr. Rundek is past president of the Neurosonology Communities of Practice of the American Institute in Ultrasound in Medicine, the largest professional medical ultrasound organization in the U.S. In Florida, she serves on the AHA South Florida board and is a recipient of the prestigious AHA Cor Vitae for Stroke Award, In the Company of Women Outstanding Woman in Science and Technology Miami-Dade Award, and the Women in Academic Medicine Career Achievement Award. In 2022, she was elected to the Academy of Science, Engineering & Medicine of Florida
